To improve upon current scientific understanding of how our feelings, emotions, and moods relate to and impact human behavior—known in the field as "affective science"—an interdisciplinary task force of 173 scientists from 23 countries, has created an integrative framework that encompasses the enormous array of affective phenomena that exist within the Human Affectome.
This organizational scheme allows vastly different scientific interests to relate to one another within the same theoretical framework, facilitating collaboration, translation, and application of affective research domains to better understand and develop treatments for mental disorders that involve severe alterations in mood, depression, and anxiety. The capstone paper, led by researchers at the Icahn School of Medicine at Mount Sinai, describing these efforts appears in Neuroscience & Biobehavioral Reviews, published online February 8.
Thousands of words are commonly used in language to describe our feelings, emotions, moods, and sensory experiences like smells, sounds, tastes, and visual imagery. These day-to-day life experiences have a significant impact on decision-making and behavior. However, they fall into many fragmented areas of study, so neuroscientists have faced a longstanding challenge to find a comprehensive and integrative framework for these experiences that can serve as a common focal point for research. Although many models have been proposed, broad agreement in support of at least a unifying framework that would host these models has been elusive and many competing perspectives exist in isolation.
To solve this challenge, the Human Affectome Project was launched in 2016 by Neuroqualia, a Canadian-based non-profit organization. The task force initially used a computational linguistics approach to scour data from more than 4.5 million books containing close to half a trillion words to identify more than 3,600 words in the English language that describe sensations, emotions, and moods. Then, 12 teams of researchers reviewed much of what is currently known about feelings, emotions, and moods from a neuroscience perspective, while simultaneously reviewing the linguistic terms that are commonly used to describe these experiences. The group then developed a model that situates these experiences within a single unifying framework. This final synthesis, which is a capstone effort, has been led by Daniela Schiller, PhD, Professor of Neuroscience, and Psychiatry, and Alessandra C. Yu, a PhD candidate in the Schiller Lab at Icahn Mount Sinai, and Leroy Lowe, PhD, President of Neuroqualia.
In this first attempt at modelling the human affectome—the conceptual umbrella that encompasses all affective experiences—each experience is marked by its valence (positive or negative) and the degree to which it is associated with energy levels or arousal. The full range of these experiences are grouped into physiological concerns (the most immediate, such as feeling hungry), operational concerns (arising through interaction with the environment, such as fear), and global concerns (our overall prospects and well-being). At the heart of this framework is an understanding that individuals are monitoring and managing various concerns simultaneously within their own comfort zones. When they are faced with experiences that are outside of these comfort zones, it creates stress and triggers restorative behaviors that are ultimately intended to preserve our well-being.
This framework will be especially helpful for those who are studying mental health disorders that involve severe alterations in emotions and mood, such as depression and anxiety. It will also help researchers better understand how feelings, emotions, and moods affect decision-making and human behavior, which is particularly important in many fields. Finally, it also has enormous implications for the field of artificial intelligence, where researchers are focused on creating computers and robots that can emulate human feelings and emotions for a wide variety of tasks.
"As neuroscientists, we are normally focused on the cognitive processes and brain mechanisms that underpin specific aspects of affective experience, so it has been quite refreshing and extremely helpful to collaborate with this group to develop a framework that can host all affective experiences with unifying terminology and agreement about their purpose. The work is expansive in scope, but this is the first time that we have had a unifying framework that brings all of these components together. Within this framework, we can now compare various models and organize them in relation to their level of investigation and goals. In this sense, this is a truly unifying endeavor—it doesn't provide one winning model but rather brings together competing models and lines of research, so that we can now construct them into an integrative understanding of the human affectome as a whole. We hope this work will energize discussions and instigate collaborations amongst many researchers," said Dr. Schiller.
About the Mount Sinai Health System
Mount Sinai Health System is one of the largest academic medical systems in the New York metro area, with more than 43,000 employees working across eight hospitals, more than 400 outpatient practices, more than 300 labs, a school of nursing, and a leading school of medicine and graduate education. Mount Sinai advances health for all people, everywhere, by taking on the most complex health care challenges of our time—discovering and applying new scientific learning and knowledge; developing safer, more effective treatments; educating the next generation of medical leaders and innovators; and supporting local communities by delivering high-quality care to all who need it. Through the integration of its hospitals, labs, and schools, Mount Sinai offers comprehensive health care solutions from birth through geriatrics, leveraging innovative approaches such as artificial intelligence and informatics while keeping patients' medical and emotional needs at the center of all treatment. The Health System includes approximately 7,400 primary and specialty care physicians; 13 joint-venture outpatient surgery centers throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and more than 30 affiliated community health centers. Hospitals within the System are consistently ranked by Newsweek's® "The World's Best Smart Hospitals, Best in State Hospitals, World Best Hospitals and Best Specialty Hospitals" and by U.S. News & World Report's® "Best Hospitals" and "Best Children's Hospitals." The Mount Sinai Hospital is on the U.S. News & World Report® "Best Hospitals" Honor Roll for 2023-2024.
About Neuroqualia
Neuroqualia is an independent non-governmental organization (NGO) based in Truro, Nova Scotia, Canada. It is an all-volunteer, non-profit, public-interest organization with a non-commercial focus. Our mission is to bring researchers together to develop a comprehensive, integrated, holistic model of affect (i.e., one that can coherently map the landscape of feelings and emotions to individual needs, motivation, attention, arousal, decision-making and a wide range of related cognitive functions). The organization has a volunteer president and a volunteer advisory board and it has been established to assemble an interdisciplinary academic task force that can produce a landmark publication in the peer-reviewed neuroscience literature to accomplish its mission. That initiative has been named The Human Affectome Project. Neuroqualia has no corporate affiliations, no intellectual property interests, no commercial interests, and no other conflicts of interest. Our goal is to advance our understanding of human feelings, motivations, and related behaviors, and we are undertaking this project for the good of humankind.
